Featured
Read our handpicked blogs, curated for you.
|
For Indian pharma, HCP engagement is no longer about reach; it’s about relevance and measurable impact. Boards want to…
|
Pharma marketing in India is at a turning point. Budgets have expanded, channels have multiplied, and compliance…
|
If you’re serious about HCP Engagement Tier 2 Cities, stop chasing metro playbooks. Tier 2 doctors don’t sit in front…
Recent releases
|
Field Force 2.0: Turning 10,000 Reps Into Digital-First Growth Drivers
The End of the Old PlaybookFor decades, pharma believed the field force was the growth engine. Hire more reps. Train them harder. Push for more calls. It worked, until it didn’t.Doctors today don’t…
|
Patient Support Programs Fail Without Personalisation at Scale
Why Most PSPs Don’t DeliverPharma has been pouring budgets into Patient Support Programs (PSPs) for years. Call centers, reminder apps, free starter kits, adherence hotlines. On paper, they look…
|
Why Pharma’s Marketing Metrics Are Broken, and What to Measure Instead
The Comfort of Easy NumbersPharma marketing loves easy metrics. Email opens. Webinar registrations. Rep call volumes. Impressions on digital ads. They look neat in a slide deck, they climb upward…
|
Patient Engagement vs Activation: A 10‑Step Playbook for Indian Pharma
Pharma companies in India are under pressure to go beyond brand promotion and focus on real patient outcomes. Engagement programs, apps, awareness campaigns, and helplines are everywhere. But the…
